DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20184772

Knowledge of pregnant women towards multiple sclerosis

Vahid Abbasi, Shervin Tabrizian, Abolfazl Atalu, Roghayeh Aslanian, Anahita Zakeri

Abstract


Background: The multiple sclerosis (MS) disease is more common in women than men with a ratio of 2.7 to 1. According to Iran MS society, there are about 80,000 MS patients in the country Iran. Having knowledge about MS can reduce significantly the anxiety and stress of pregnant women and promote their life expectancy and the probability of having a successful pregnancy and making pregnancy easier for them.

Methods: This is a descriptive– analytical study that has been done on 150 pregnant women which selected randomly and referred to health centers of Ardabil city at 2017. Data collected by a questionnaire included questions about MS. The collected data were analyzed by statistical methods in SPSS version 19.

Results: Of all women, 20% considered gender as one of the most effective factors in the disease and 44.7% believed that women are more likely to suffer from MS than men. The knowledge of pregnant women about MS with 63.3% was in moderate level and friends and relatives was the most source of their awareness. 43.3% of women believed that knowledge people with MS could marry. 63.3% of women pointed that the health care centers knowledge about MS was inadequate and 68.7% pointed that government's support for patients was significantly low.

Conclusions: Results showed that the awareness of pregnant women about MS was in moderate level. So, planning to increase the awareness of pregnant women in centers and support of women with MS by governmental centers seems necessary.


Keywords


Multiple sclerosis, Awareness, Women, Ardabil

Full Text:

PDF

References


Soldan SS, Retuerto AIA, Sicotte NL, Voskuhl RR. Immune modulation in multiple sclerosis patients treated with the pregnancy hormone estriol. J Immunol. 2003;171(11):6267-74.

Lee M, O’brien P. Pregnancy and multiple sclerosis. J Neurol Neurosurg Psychiatry. 2008;79(12):1308-11.

Miranda-Hernandez S, Baxter AG. Role of toll-like receptors in multiple sclerosis. Am J Clin Experimental Immunol. 2013;2(1):75.

Franklin GM, Nelson L. Environmental risk factors in multiple sclerosis Causes, triggers, and patient autonomy. Neurology. 2003;61(8):1032-4.

Goldenberg MM. Multiple sclerosis review. Pharmacy and Therapeutics. 2012;37(3):175.

Hamid N, Mehrabizadeh M, Sadeghi S. The Effect of Stress Inoculation Training (SIT) on Depression and Quality of Life in Multiple Sclerosis (MS) Patients with Control of Duration of Disease in Esfahan City. Jundishapur Scientific Med J. 2012;11:77-84.

Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, et al. Depression and anxiety in multiple sclerosis. A clinical and MRI study in 95 subjects. J Neurol. 2001;248(5):416-21.

Hamid N, Mehrabi Zadeh Honarmand M, Sadeghi S. The Effect of Stress Inoculation Training (SIT) on Depression and Quality of Life in Multiple Sclerosis (MS) Patients with Control of Duration of Disease in Esfahan City. Jundishapur Scientific Medical J. 2012.

Korostil M, Feinstein A. Anxiety disorders and their clinical correlates in multiple sclerosis patients. Multiple Sclerosis J. 2007;13(1):67-72.

Korn‐Lubetzki I, Kahana E, Cooper G, Abramsky O. Activity of multiple sclerosis during pregnancy and puerperium. Annals of Neurol. 1984;16(2):229-31.

Manouchehri E, Fathi Najafi T, Saeedi M, Bahri N. Menstrual pattern in women with Multiple Sclerosis. IJOGI. 2017;19(38):42-7.

Birk K, Ford C, Smeltzer S, Ryan D, Miller R, Rudick RA: The clinical course of multiple sclerosis during pregnancy and in the puerpurium. Arch Neurol. 1990;47:738-42.

Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T: Rate of pregnancy-related relapse in multiple sclerosis. The N Eng J Med. 1998;339:285-91.

Whitaker JN. Effects of pregnancy and delivery on disease activity in multiple sclerosis. N Eng J Med. 1998;339:339-40.

Worthington J, Jones R, Crawford M, Forti A: Pregnancy and multiple sclerosis-a 3 year prospective Study. J Neurol. 1994;241:228-33.

Amani F, Hoseinzadeh S, Sabzvari A, Avesta L, Kahnamouei-Aghdam F, Barak M. Awareness rate of Ardabil city people about multiple sclerosis. Int J Advances Med. 2017;2(2):156-9.

Polman CH. Drug treatment of multiple sclerosis. Bmj. 2000;321(7259):490-4.

Duquette P, Pleines J, Girard M, Charest L, Senecal-Quevillon M, Masse C. The increased susceptibility of women to multiple sclerosis. Canadian J Neurological Sci. 1992;19(4):466-71.

Schuurs A, Verheul H. Effects of gender and sex steroids on the immune response. Journal of steroid biochemistry. 1990;35(2):157-72.

Confavreux C, Hutchinson M, Hours MM, Cortinovis-Tourniaire P, Moreau T, Group PiMS. Rate of pregnancy-related relapse in multiple sclerosis. N Eng J Med. 1998;339(5):285-91.

Vukusic S. The Pregnancy In Multiple Sclerosis G, Hutchinson M, the Pregnancy In Multiple Sclerosis G, Hours M, the Pregnancy In Multiple Sclerosis G, et al. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post‐partum relapse. Brain. 2004;127(6):1353-60.

Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. The Lancet Neurology. 2010;9(7):727-39.

Di Pauli F, Reindl M, Ehling R, Schautzer F, Gneiss C, Lutterotti A, et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis. Multiple Sclerosis J. 2008;14(8):1026-30.

Finkelsztejn A, Brooks J, Paschoal Jr F, Fragoso Y. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta‐analysis of the literature. BJOG: An Int J Obstet Gynaecol. 2011;118(7):790-7.

Achiron A, Kishner I, Dolev M, Stern Y, Dulitzky M, Schiff E, et al. Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis. J Neurol. 2004;251(9):1133-7.

Albrecht et al. Multiple sclerosis and pregnancy: what does the patient think? a questionnaire study. BMC Research Notes. 2010;3:91.

Brookings W, Lee M. Management of MS during pregnancy. Progress in neurology and psychiatry. Available at: www.progressnp.com.

Nortvedt MW, Riise T, Maeland J. Multiple sclerosis and lifestyle factors: the Hordaland Health Study. Neurological Sci. 2005;26(5):334-9.

Dahl J, Myhr KM, Daltveit AK, Gilhus NE. Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis. J Neurol. 2008;255(5):623-7.